Ignite Creation Date:
2024-05-06 @ 1:23 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01799798
Status:
COMPLETED
Last Update Posted:
2015-01-27
First Post:
2013-02-14
Brief Title:
Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab
Sponsor:
University of Cologne
Organization:
University of Cologne
Organization Data
Organization:
University of Cologne
Class:
OTHER
Study ID:
Uni-Koeln-1574
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Cologne
Lead Sponsor Class:
OTHER
Responsible Party:
Dr med Joerg Oliver Semler
Responsible Party Title:
Head of the outpatient center for sceletal dysplasias
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Cologne
Old Name:
None
Old Organization:
None